Fiscal Year End Company Status Exempt Flag May 31 Delist N Incorporation Locations Inc. Date Expiry Date Country Region Description 1/Nov/2004  8/Jul/2014  Canada  British Columbia    Exchange Filing Office Location (not available)		Business Type(s) Primary/Secondary Business Type Details Primary  *Research And Development In The Life Sciences  About Welichem Biotech Inc. (From News Release January 3, 2013) Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancer. For a more complete business and financial profile of the Company, interested parties are encouraged to visit the Company's website, www.welichem.com.   Securities Symbol Security Name Market Status *WBI *Welichem Biotech Inc. TSX Venture DELIST *WBI.RT *Welichem Biotech Inc rt ex 20aug2010 TSX Venture DELIST *WBI *Welichem Biotech Inc. old TSX Venture DELIST Name History From To *Welichem Biotech Inc. 2/Nov/2004 8/Jul/2014 Company Facts Reconciliation Subject Date Returned Summer 2013 CFR 11/Jun/2013 Associations Auditing Firm:  *Ernst & Young LLP Lawyer:  *Larry Yen Law Firm:  *Clark Wilson LLP Transfer Agent:  *Computershare Investor Services Inc.   *Computershare Trust Company of Canada
Latest Information Type Date Title News Releases  30/Jun/2014  NEWS RELEASE - WELICHEM RESPONDS TO COMPLETION OF TAKE-OVER BID[CANADA NEWSWIRE]     NEWS RELEASE - HALT[MARKET NEWS]     NEWS RELEASE - IIROC TRADING HALT RE WELICHEM BIOTECH INC. PEND[MARKET NEWS] Bulletins  8/Jul/2014  Delist Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data